Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Melanie Moyo

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 28, 2025
ART Management in Cryptococcal MeningitisMelanie Moyo, Joseph N Jarvis
The Lancet. Microbe|February 11, 2024
Development and validation of quantitative PCR assays for HIV-associated cryptococcal meningitis in sub-Saharan Africa: a diagnostic accuracy studyTshepiso Mbangiwa, Aude Sturny-Leclère, Kwana Lechiile, et al.
The Journal of Antimicrobial Chemotherapy|March 1, 2023
Population pharmacokinetics and CSF penetration of flucytosine in adults with HIV-associated cryptococcal meningoencephalitisKatharine E Stott, Ajisa Ahmadu, Cheusisime Kajanga, et al.
Open Forum Infectious Diseases|April 24, 2025
Relative Contribution of Pharmacokinetics and Immune Signatures to Clinical Outcomes in Patients With HIV-associated Cryptococcal MeningitisKatharine E Stott, Dumizulu Tembo, Cheusisime Kajanga, et al.
Mbio|August 27, 2024
Integration of genomic and pharmacokinetic data to predict clinical outcomes in HIV-associated cryptococcal meningitisKatharine E Stott, Jason T Mohabir, Katharine Bowers, et al.
The Journal of Antimicrobial Chemotherapy|November 21, 2022
Population pharmacokinetics of liposomal amphotericin B in adults with HIV-associated cryptococcal meningoencephalitisKatharine E Stott, Melanie Moyo, Ajisa Ahmadu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 3, 2025
Recent Antiretroviral Therapy Initiation Is Associated With Increased Mortality Risk in HIV-associated Cryptococcal Meningitis: An Analysis of Clinical Trial Data From AfricaMelanie Moyo, David S Lawrence, James Jafali, et al.
Journal of the International AIDS Society|June 6, 2025
Household economic impact of HIV-associated cryptococcal meningitis in five countries in Southern and Eastern AfricaDavid S Lawrence, Charles Muthoga, Jack Adams, et al.
The Lancet. Global Health|November 18, 2022
Cost-effectiveness of single, high-dose, liposomal amphotericin regimen for HIV-associated cryptococcal meningitis in five countries in sub-Saharan Africa: an economic analysis of the AMBITION-cm trialDavid S Lawrence, Charles Muthoga, David B Meya, et al.
The New England Journal of Medicine|March 23, 2022
Single-Dose Liposomal Amphotericin B Treatment for Cryptococcal MeningitisJoseph N Jarvis, David S Lawrence, David B Meya, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 28, 2025
ART Management in Cryptococcal MeningitisMelanie Moyo, Joseph N Jarvis
The Lancet. Microbe|February 11, 2024
Development and validation of quantitative PCR assays for HIV-associated cryptococcal meningitis in sub-Saharan Africa: a diagnostic accuracy studyTshepiso Mbangiwa, Aude Sturny-Leclère, Kwana Lechiile, et al.
The Journal of Antimicrobial Chemotherapy|March 1, 2023
Population pharmacokinetics and CSF penetration of flucytosine in adults with HIV-associated cryptococcal meningoencephalitisKatharine E Stott, Ajisa Ahmadu, Cheusisime Kajanga, et al.
Open Forum Infectious Diseases|April 24, 2025
Relative Contribution of Pharmacokinetics and Immune Signatures to Clinical Outcomes in Patients With HIV-associated Cryptococcal MeningitisKatharine E Stott, Dumizulu Tembo, Cheusisime Kajanga, et al.
Mbio|August 27, 2024
Integration of genomic and pharmacokinetic data to predict clinical outcomes in HIV-associated cryptococcal meningitisKatharine E Stott, Jason T Mohabir, Katharine Bowers, et al.
The Journal of Antimicrobial Chemotherapy|November 21, 2022
Population pharmacokinetics of liposomal amphotericin B in adults with HIV-associated cryptococcal meningoencephalitisKatharine E Stott, Melanie Moyo, Ajisa Ahmadu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 3, 2025
Recent Antiretroviral Therapy Initiation Is Associated With Increased Mortality Risk in HIV-associated Cryptococcal Meningitis: An Analysis of Clinical Trial Data From AfricaMelanie Moyo, David S Lawrence, James Jafali, et al.
Journal of the International AIDS Society|June 6, 2025
Household economic impact of HIV-associated cryptococcal meningitis in five countries in Southern and Eastern AfricaDavid S Lawrence, Charles Muthoga, Jack Adams, et al.
The Lancet. Global Health|November 18, 2022
Cost-effectiveness of single, high-dose, liposomal amphotericin regimen for HIV-associated cryptococcal meningitis in five countries in sub-Saharan Africa: an economic analysis of the AMBITION-cm trialDavid S Lawrence, Charles Muthoga, David B Meya, et al.
The New England Journal of Medicine|March 23, 2022
Single-Dose Liposomal Amphotericin B Treatment for Cryptococcal MeningitisJoseph N Jarvis, David S Lawrence, David B Meya, et al.
Pageof 1